Aster Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$141K Buy
+731
New +$119K 0.05% 401
2025
Q2
– Sell
-7,452
Closed -$1.19M – 1488
2025
Q1
$1.19M Buy
+7,452
New +$1.15M 0.22% 124

Other funds holding RGEN

Aster Capital Management's RGEN Position: Q3 2026 in Review

Aster Capital Management opened a new position in Repligen (RGEN) in Q3 2026: 731 shares worth $141K. The stake represents 0.05% of the portfolio and ranks #401 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in RGEN as recently as Q1 2025.

Aster Capital Management first reported a position in RGEN in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.19M in Q1 2025. 519 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Aster Capital Management held 731 shares of Repligen worth $141K as of Q3 2026.
  • Repligen was a new Aster Capital Management position in Q3 2026.
  • Repligen made up 0.05% of Aster Capital Management's portfolio in Q3 2026, its #401 holding.
  • Aster Capital Management first reported a position in Repligen in Q1 2025 and has held it in 2 quarters since.
  • Aster Capital Management's Repligen position peaked at $1.19M in Q1 2025.
  • 519 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.